Chemotherapy-elicited upregulation of NKG2D and DNAM-1 ligands as a therapeutic target in multiple myeloma

OncoImmunology

Volumn 2, Issue 12, 2013, Pages

  Soriani, Alessandra ^a   Fionda, Cinzia ^a   Ricci, Biancamaria ^a   Iannitto, Maria Luisa ^a   Cippitelli, Marco ^a   Santoni, Angela ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

DNAM 1; Multiple myeloma; NK cells; NKG2D; Tumor immunology

Indexed keywords

CD155 ANTIGEN; GLYCOGEN SYNTHASE KINASE 3; HEAT SHOCK PROTEIN 90; HEAT SHOCK TRANSCRIPTION FACTOR 1; LENALIDOMIDE; LYMPHOCYTE ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1 POLYPEPTIDE RELATED SEQUENCE A; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1 POLYPEPTIDE RELATED SEQUENCE B; MELPHALAN; MESSENGER RNA; NATURAL KILLER CELL RECEPTOR NKG2D; NECTIN 2; RADICICOL; STAT3 PROTEIN; TANESPIMYCIN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; ATAXIA TELANGIECTASIA; CANCER CHEMOTHERAPY; CARCINOGENESIS; DNA DAMAGE; DRUG POTENTIATION; ENZYME INDUCTION; ENZYME INHIBITION; G2 PHASE CELL CYCLE CHECKPOINT; HUMAN; IMMUNOSURVEILLANCE; IN VITRO STUDY; IN VIVO STUDY; MULTIPLE MYELOMA; NATURAL KILLER CELL; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 84896692416     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.4161/onci.26663     Document Type: Article

References (10)

1. Guerra N, Tan YX, Joncker NT, Choy A, Gallardo F, Xiong N, Knoblaugh S, Cado D, Greenberg NM, Raulet DH. NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy. Immunity 2008; 28:571-80; PMID:18394936; http://dx.doi.org/10.1016/j. immuni.2008.02.016
2. Iguchi-Manaka A, Kai H, Yamashita Y, Shibata K, Tahara-Hanaoka S, Honda S, Yasui T, Kikutani H, Shibuya K, Shibuya A. Accelerated tumor growth in mice deficient in DNAM-1 receptor. J Exp Med 2008; 205:2959-64; PMID:19029379; http:// dx.doi.org/10.1084/jem.20081611
3. El-Sherbiny YM, Meade JL, Holmes TD, McGonagle D, Mackie SL, Morgan AW, Cook G, Feyler S, Richards SJ, Davies FE, et al. The requirement for DNAM-1, NKG2D, and NKp46 in the natural killer cell-mediated killing of myeloma cells. Cancer Res 2007; 67:8444-9; PMID:17875681; http://dx.doi. org/10.1158/0008-5472.CAN-06-4230
4. Soriani A, Zingoni A, Cerboni C, Iannitto ML, Ricciardi MR, Di Gialleonardo V, Cippitelli M, Fionda C, Petrucci MT, Guarini A, et al. ATM-ATRdependent up-regulation of DNAM-1 and NKG2D ligands on multiple myeloma cells by therapeutic agents results in enhanced NK-cell susceptibility and is associated with a senescent phenotype. Blood 2009; 113:3503-11; PMID:19098271; http://dx.doi. org/10.1182/blood-2008-08-173914
5. Krizhanovsky V, Yon M, Dickins RA, Hearn S, Simon J, Miething C, Yee H, Zender L, Lowe SW. Senescence of activated stellate cells limits liver fibrosis. Cell 2008; 134:657-67; PMID:18724938; http:// dx.doi.org/10.1016/j.cell.2008.06.049
6. Kang TW, Yevsa T, Woller N, Hoenicke L, Wuestefeld T, Dauch D, Hohmeyer A, Gereke M, Rudalska R, Potapova A, et al. Senescence surveillance of premalignant hepatocytes limits liver cancer development. Nature 2011; 479:547-51; PMID:22080947; http://dx.doi.org/10.1038/nature10599
7. Trepel J, Mollapour M, Giaccone G, Neckers L. Targeting the dynamic HSP90 complex in cancer. Nat Rev Cancer 2010; 10:537-49; PMID:20651736; http://dx.doi.org/10.1038/nrc2887
8. Fionda C, Soriani A, Malgarini G, Iannitto ML, Santoni A, Cippitelli M. Heat shock protein-90 inhibitors increase MHC class I-related chain A and B ligand expression on multiple myeloma cells and their ability to trigger NK cell degranulation. J Immunol 2009; 183:4385-94; PMID:19748980; http://dx.doi. org/10.4049/jimmunol.0901797
9. Luo J. Glycogen synthase kinase 3beta (GSK3beta) in tumorigenesis and cancer chemotherapy. Cancer Lett 2009; 273:194-200; PMID:18606491; http://dx.doi. org/10.1016/j.canlet.2008.05.045
10. Fionda C, Malgarini G, Soriani A, Zingoni A, Cecere F, Iannitto ML, Ricciardi MR, Federico V, Petrucci MT, Santoni A, et al. Inhibition of glycogen synthase kinase-3 increases NKG2D ligand MICA expression and sensitivity to NK cell-mediated cytotoxicity in multiple myeloma cells: role of STAT3. J Immunol 2013; 190:6662-72; PMID:23686482; http:// dx.doi.org/10.4049/jimmunol.1201426